Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy

Neuroscience Research

Volumn 36, Issue 3, 2000, Pages 183-191

  Takamori, Masaharu ^a   Maruta, Takahiro ^a   Komai, Kiyonobu ^b  

^a Neurological Center   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmunity; Calcium channel; Lung cancer; Myasthenic syndrome; Neuromuscular transmission; Paraneoplastic syndrome; Synaptotagmin

Indexed keywords

CALCIUM CHANNEL; SYNAPTOTAGMIN;

ANTIGENICITY; AUTOIMMUNITY; CROSS REACTION; EATON LAMBERT SYNDROME; HUMAN; IMMUNOPATHOGENESIS; LUNG SMALL CELL CANCER; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0033955694     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00135-2     Document Type: Article

References (44)

1. Chapman E.R., Jahn R. Calcium-dependent interaction of cytoplasmic region of synaptotagmin with membanes. J. Biol. Chem. 269:1994;5735-5741.
2. Cull-Candy S.G., Miledi R., Trautmann A., Uchitel O.D. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plate. J. Physiol. (Lond). 299:1989;621-638.
3. David P., El Far O., Martin-Mouto N., Poupon M.F., Takahashi M., Seagar M.J. Expression of synaptotagmin and syntaxin associated with N-type calcium channels in small cell lung cancer. FEBS Lett. 326:1993;135-139.
4. 2+ channels in mammalian central neurons. Trends Neurosci. 18:1995;89-98.
5. 2+ interactions. Neuron. 15:1995;1121-1132.
6. Elmqvist D., Lambert E.H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin. Proc. 43:1968;689-713.
7. Fukuoka T., Engel A.G., Lang B., Newsom-Davis J., Vincent A. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate. Ann. Neurol. 22:1987;200-211.
8. Gutmann L., Phillips L.H., Gutmann L. Trends in the association of Lambert-Eaton syndrome with carcinoma. Neurology. 42:1992;848-850.
9. Iwasa, K., Takamori, M., Komai, K., Mori, Y, 2000. Recombinant calcium channel is recognized by Lambert-Eaton masthenic syndrome antibodies. Neurology (in press).
10. Kelly R.B. Synaptotagmin is just a calcium sensor. Curr. Biol. 5:1995;257-259.
11. Komai K., Iwasa K., Takamori M. Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. J. Neurol. Sci. 166:1999;126-130.
12. Lang B., Newsom-Davis J., Prior C., Wray D. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J. Physiol. (Lond). 344:1983;335-345.
13. Lang B., Newsom-Davis J., Peers C., Prior C., Wray D. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J. Physiol. (Lond). 390:1987;257-270.
14. 2+ flux in tumor cells correlates with disease severity. Ann. Neurol. 25:1989;265-271.
15. Lennon V.A., Lambert E.H. Autoantibodies bind solubilized calcium channel omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin. Proc. 64:1989;1498-1504.
16. Lennon V.A., Lambert E.H., Leiby K.R., Okarma T.B., Talib S. Recombinant human acetylcholine receptor a-subunit induces chronic experimental autoimmune myasthenia gravis. J. Immunol. 146:1991;2245-2248.
17. Lennon V.A., Kryzer T.J., Griesmann G.E., O'Suilleabhain P.E., Windebank A.J., Woppmann A. et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N. Engl. J. Med. 332:1995;1467-1474.
18. Leys K., Lang B., Johnston I., Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann. Neurol. 29:1991;307-314.
19. Mason W.P., Graus F., Lang B., Honnorat J., Delattre J.-Y., Valderoriola F. et al. Samll-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 120:1997;1279-1300.
20. Matteoli M., Takei K., Perin M.S., Sudhof T.C., DeCamilli P. Exo-endocytotic recycling of synaptic vesicles in developing processes of cultured hippocampal neurons. J. Cell Biol. 117:1992;859-861.
21. McCann F.A., Pettengill O.S., Cole J.J., Russell J.A.G., Sorenson G.D. Calcium spike electrogenesis and other electrical activity in continuously cultured small cell carcinoma of the lung. Science. 212:1981;1155-1157.
22. Meriney S.D., Hulsizer S.C., Lennon V.A., Grinnell A.D. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann. Neurol. 40:1996;739-749.
23. Mori Y., Friefdreich T., Kim M.-S., Mikami A., Nakai J., Ruth P. et al. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature. 350:1991;398-402.
24. Motomura M., Lang B., Johnston I., Palace J., Vincent A., Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J. Neurol. Sci. 147:1997;35-42.
25. Nagel A., Engel A.G., Lang B., Newsom-Davis J., Fukuoka T. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann. Neurol. 24:1988;552-558.
26. O'Neill J.H., Murray N.M.F., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 111:1988;577-596.
27. 2+ channel gene CACNL1A4. Cell. 87:1996;543-552.
28. Ousley A.H., Froehner S.C. An anti-peptide antibody specific for the class A calcium channel a 1 subunit labels mammalian neuromuscular junction. Proc. Natl. Acad. Sci. USA. 91:1994;12263-12267.
29. Perin M.S., Johnston P.A., Özelk T., Jahn R., Fraucke U., Südhof T.C. Structural and functional conservation of synaptotagmin (p56) in Dorsophila and human. J. Biol. Chem. 266:1991;615-622.
30. Posner, J.B., 1995. Paraneoplastic syndrome. In: Posner, J.B. (Ed.), Neurological Complication of Cancer. FA Davis Company, Philadelphia, pp. 245-278.
31. Protti D.A., Reisin R., Mackinley T.A., Uchitel O.D. Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology. 46:1996;1391-1396.
32. 2+ flux in a small cell lung carcinoma line. Nature. 317:1985;737-739.
33. Südhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653.
34. 2+/calmodulin-dependent protein kinase II phosphorylate a novel 58 kDa protein in synaptic vesicles. Brain Res. 551:1991;279-292.
35. Takamori M., Hamada T., Komai K., Takahashi M., Yoshida A. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann. Neurol. 35:1994;74-80.
36. Takamori M., Takahashi M., Yasukawa Y., Iwasa K., Nemoto Y., Suenaga A. et al. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. J. Neurol. Sci. 133:1995;95-101.
37. Takamori M., Iwasa K., Komai K. Antibodies to synthetic peptides of the α 1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome. Neurology. 48:1997;1261-1265.
38. Takamori, M. (Chief of the project group on paraneoplastic neurological syndromes, Neuroimmunological Disease Research Committee, Ministry of Health and Welfare of Japan), 1997. A nationwide survey on paraneoplastic syndromes. Clin Neurol 37, 93-98.
39. Takamori M., Iwasa K., Komai K. Antigenic sites of the voltage-gated calcium channel in Lambert-Eaton myashenic syndrome. Ann. N.Y. Acad. Sci. 841:1998;625-635.
40. Takamori M. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome. Int. Med. 38:1999;86-96.
41. Tournier-Lasserve E. CACNA1A mutations: hemiplegic migraine, episodic ataxia type 2, and the others (Editorial). Neurology. 53:1999;3-4.
42. 2+ channel function and drug action. Trends Pharmacol. Sci. 16:1995;43-49.
43. Vincent A., Lang B., Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lamert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci. 12:1989;496-502.
44. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D.W., Amos C. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α 1A voltage-dependent calcium channel. Nat. Genet. 15:1997;62-69.